Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Germany Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20054
20062
20081
20092
20111
20124
20138
20142
20153
20161
20171
20191
20221
20233
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting4
Active, not recruiting2
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
Sanofi5
Kowa Research Europe4
Novartis Pharmaceuticals4
AstraZeneca3
Merck Sharp & Dohme LLC3
Kastle Therapeutics, LLC2
Regeneron Pharmaceuticals2
Takeda2
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia43
Hyperlipidemias10
Dyslipidemias9
Hyperlipoproteinemia Type II4
Aortic Valve Stenosis2
Atherosclerosis2
Cardiovascular Diseases2
Coronary Disease2
Heart Failure2
Homozygous Familial Hypercholesterolemia2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.